Position in OGN
as of Jun 30, 2026
· filed Aug 25, 2026
Position Value
$10,498,672
+$10,495,084 QoQ
Shares Held
775,382
+230668.5% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#46
of 630 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Groupe la Francaise holds $505,348,073 across 12 Drug Manufacturers - General names. OGN ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
143,142 | $171,688,823 | |
| 2 | AZN |
Astrazeneca PLC
|
810,732 | $153,731,001 | |
| 3 | ABBV |
AbbVie Inc.
|
303,838 | $76,457,794 | |
| 4 | JNJ |
Johnson & Johnson
|
198,681 | $50,459,013 | |
| 5 | MRK |
Merck & Co., Inc.
|
260,892 | $33,524,622 | |
| 6 | OGN |
Organon & Co.
This page
|
775,382 | $10,498,672 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
49,627 | $6,269,875 | |
| 8 | GRFS |
Grifols SA
|
238,928 | $1,691,610 |
All Filings in OGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,498,672 | 775,382 | Shares | Defined | 2026-08-25 | |
| 2025-09-30 | $3,588 | 336 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $744 | 50 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||